Outlook Therapeutics, Inc. - COM NEW (OTLK)

Historical Portfolio Holders from Q1 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
312 K
Holdings value Q1 2024
$3.73 M
Value change Q1 2024
-$7.7 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
2
Number of buys Q1 2024
1
Number of sells Q1 2024
-78
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
69012T206
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 312 K $3.73 M -$7.7 M $11.27 2
2023 Q4 28.9 M $11.4 M +$977 K $0.39 82
2023 Q3 26.8 M $5.91 M -$5.45 M $0.22 75
2023 Q2 29.1 M $50.7 M +$3.73 M $1.74 83
2023 Q1 27.1 M $29.6 M -$243 K $1.09 77
2022 Q4 27.4 M $29.6 M +$3.58 M $1.08 74
2022 Q3 23.9 M $29.2 M -$940 K $1.22 70
2022 Q2 24.7 M $25.2 M -$944 K $1.02 66
2022 Q1 25.2 M $45.1 M +$2.82 M $1.78 67
2021 Q4 23.9 M $32.5 M +$3.82 M $1.36 66
2021 Q3 21.1 M $46 M +$1.93 M $2.17 61
2021 Q2 20.2 M $50.2 M +$17.5 M $2.49 59
2021 Q1 13.4 M $30.2 M +$16.9 M $2.25 48
2020 Q4 5.94 M $7.72 M +$2.85 M $1.30 27
2020 Q3 3.85 M $2.77 M +$1.52 M $0.72 25
2020 Q2 1.68 M $2.17 M -$2.3 M $1.30 17
2020 Q1 5.93 M $3.57 M +$2.76 M $0.60 15
2019 Q4 1.44 M $847 K +$220 K $0.59 12
2019 Q3 943 K $1.41 M +$142 K $1.49 13
2019 Q2 828 K $1.72 M +$1.33 M $2.07 11
2019 Q1 121 K $895 K +$895 K $7.41 10